Home
/
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON) Technical Analysis
Updated: 2026-05-01 03:18 UTC · Last close: 66.74 (+3.07%) · Support: 64.14
CG Oncology, Inc. (CGON) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
Quick Read
Downside line to hold: 64.14 remains the key nearby support reference.
📊 Technical Summary
The latest close for CG Oncology, Inc. (CGON) came in at 66.74 (+3.07%). Price continues to hold above both the 50-day and 200-day moving averages, which keeps the broader trend structure constructive. 20-day momentum is running at -0.07%; price is trading in the upper part of its roughly 52-week range (21.70–73.43); and ATR14 volatility is elevated at roughly 5.10% of price. RSI(14) stands around 49.5, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. On the downside, 64.14 is the first support area. Holding above it helps keep the current structure more stable. Fundamentals snapshot: Revenue: 1.67M · Net income: -161.00M · EPS (basic): -0.57. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
CG Oncology, Inc.
Note: This is an algorithmic technical snapshot (not financial advice).